2009 Annual Physicians' CME Preferences Survey

Two-thirds of physicians surveyed believe the quality of the continuing medical education they receive varies depending on the type of provider. The question is, whom do they trust?

Two major pharmaceutical companies — GlaxoSmithKline and Pfizer — recently changed their continuing medical education granting process to eliminate medical education and communication companies as prospective recipients of unrestricted grants. To many CME providers, this seems like a vote of no confidence in MECCs' ability to provide high-quality, independent, unbiased, and effective CME, compared to societies, academic centers, and others who provide accredited CME. What w

Register to view the full article

Register for MeetingsNet.com and gain access to premium content including the CMI 25 Listing, our monthly digital edition, the MeetingsNet app, live and on-demand webinars, and much more.

Already a member? .

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.